PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 128 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,823,284 | +27.2% | 63,024 | +0.8% | 0.00% | +100.0% |
| Q4 2023 | $1,433,515 | +71.5% | 62,517 | +24.8% | 0.00% | 0.0% |
| Q3 2023 | $835,885 | -51.8% | 50,113 | -20.2% | 0.00% | -50.0% |
| Q2 2023 | $1,735,475 | +98.6% | 62,834 | +65.3% | 0.00% | +100.0% |
| Q1 2023 | $874,023 | +156.5% | 38,001 | +21.7% | 0.00% | – |
| Q4 2022 | $340,796 | +26.2% | 31,237 | -2.5% | 0.00% | – |
| Q3 2022 | $270,000 | +7.6% | 32,032 | +0.7% | 0.00% | – |
| Q2 2022 | $251,000 | -67.8% | 31,815 | -3.3% | 0.00% | -100.0% |
| Q1 2022 | $779,000 | -19.6% | 32,898 | +16.1% | 0.00% | 0.0% |
| Q4 2021 | $969,000 | +97.4% | 28,348 | +2.4% | 0.00% | – |
| Q3 2021 | $491,000 | -60.1% | 27,695 | +0.9% | 0.00% | -100.0% |
| Q2 2021 | $1,231,000 | +124.2% | 27,455 | +29.3% | 0.00% | – |
| Q1 2021 | $549,000 | -46.4% | 21,240 | -58.2% | 0.00% | -100.0% |
| Q4 2020 | $1,025,000 | +90.9% | 50,823 | +85.0% | 0.00% | – |
| Q3 2020 | $537,000 | +50.0% | 27,476 | +62.3% | 0.00% | – |
| Q3 2016 | $358,000 | – | 16,924 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $84,864,191 | 21.18% |
| Cannon Global Investment Management, LLC | 69,900 | $2,422,035 | 11.28% |
| ADAR1 Capital Management, LLC | 1,603,932 | $55,576,244 | 10.49% |
| Checkpoint Capital L.P. | 355,000 | $12,300,750 | 7.42% |
| Fairmount Funds Management LLC | 931,890 | $32,289,989 | 3.65% |
| BVF INC/IL | 3,319,290 | $115,013,399 | 3.22% |
| RTW INVESTMENTS, LP | 5,286,404 | $183,173,899 | 2.84% |
| Kynam Capital Management, LP | 800,000 | $27,720,000 | 2.14% |
| 683 Capital Management, LLC | 604,449 | $20,944,158 | 1.58% |
| Birchview Capital, LP | 48,000 | $1,663,200 | 1.54% |